Literature DB >> 15160966

Allogeneic bone marrow transplantation from an unrelated donor for the treatment of chronic myelogenous leukemia in blast crisis in a patient with Kleinfelter's syndrome.

Tomomi Toubai1, Junji Tanaka, Shuichi Ota, Yoko Miura, Nobuyasu Toyoshima, Masahiro Asaka, Masahiro Imamura.   

Abstract

We describe the first reported Klinefelter's syndrome (KS) in which allogeneic bone marrow transplantation from an unrelated donor (UR-BMT) was performed for treatment of chronic myelogenous leukemia in blast crisis (CML-BC). A 31-year-old male patient was diagnosed as having CML-BC with KS in April 2001. The result of a bone marrow chromosomal examination were 47, XXY, t(9;22)(q34;q11). After he had been treated with chemotherapy and imatinib mesylate, he underwent UR-BMT in February 2002. After the UR-BMT, his bone marrow chromosome changed from 47, XXY, t(9;22)(q34;q11) to 46,XY and 100% donor-type chimerism was obtained. However, he relapsed on day 83 after UR-BMT. After treatment with imatinib mesylate and tapering of immunosuppressive agents, skin and liver GVHD developed and then donor-type chimerism was increased with decreased blast cells. However, the patient died due to progression of disease in October 2002.

Entities:  

Mesh:

Year:  2004        PMID: 15160966     DOI: 10.1080/10428190310001607188

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

1.  Successful bone marrow transplantation for treatment of chronic myeloid leukemia from a donor with mosaic Klinefelter syndrome.

Authors:  Said Ismail; Wafa Qubbaj; Mona Kilani; Miza Hijazi; Amid Abdelnour; Mohammed S Al-Khateeb; Abdalla Awidi
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

2.  Leukemia in Patients with Klinefelter Syndrome: A Report of Two Cases.

Authors:  M Bchir; W Ayed; H Ben Neji; O Kilani; S Kefi; M Zarrouk; H Guermani; S Hentati; A Amouri; B Meddeb
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-02       Impact factor: 0.900

3.  Persistent suboptimal molecular response in a patient with chronic myelogenous leukemia and Klinefelter syndrome.

Authors:  Rajshekhar Chakraborty; Shiva Kumar Reddy Mukkamalla; Kranthi Singam; Natalia Calderon
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

4.  Chronic myeloid leukemia in case of Klinefelter syndrome.

Authors:  Vasundhara Chennuri; Rajesh Kashyap; Parag Tamhankar; Subha Phadke
Journal:  Indian J Hum Genet       Date:  2014-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.